1. Ansseau M, Doumont A, Thiry D, Gelders Y (1983) Pilot study of a specific serotonergic antagonist, piremperone, in the treatment of anxiety disorders. Acta Psychiat Belg 83:517?524
2. Beretta C, Ferrini R, Glässer AH (1965) 1-Methyl-8?-carbobenzyloxy-aminomethyl-10-?-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature 207:421?422
3. Biaggio AMB, Natalício L, Spielberger CD (1976) The development and validation of an experimental portuguese form of the state-trait anxiety inventory. In: Spielberger CD, Diaz-Guerrero R (eds) Cross-cultural research on anxiety. Hemisphere/Wiley, Washington, DC, p 29
4. Bloomfield SS, Tetreault L, Lafrenière B, Bordeleau JM (1967) A method for the evaluation of hypnotic agents in man. Comparative hypnotic effects of secobarbital, methaqualone and placebo in normal subjects and in psychiatric patients. J Pharmacol Exp Ther 156:375?382
5. Commissaris RL, Rech RH (1982). Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat. Psychopharmacology 76:282?285